Mesalamine Tablet, Delayed Release
Product Images NDC 68382-711

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68382-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

438a8c72 38e5 4d31 A2b0 418c6366ecbd 01

Chemical structure diagram of mesalamine, showing its molecular framework with functional groups including an amine (NH2), hydroxyl (OH), and carboxyl (COOH) attached to a benzene ring.*

FDA Label Image

438a8c72 38e5 4d31 A2b0 418c6366ecbd 02

Label for Mesalamine Delayed-Release Tablets, USP, 1.2 g strength, oral route, packaged as 120 tablets. The label shows the brand name Mesalamine, dosage strength of 1.2 g, a barcode, NDC 68382-711-19, and instructions including storage and dispensing warnings. It is distributed by Zydus Pharmaceuticals USA Inc., with manufacturing by Cadila Healthcare Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.